Hodgkin lymphoma trials in Finland
2 trials · From EU CTIS (euclinicaltrials.eu), checked 13 November 2026. Ask the study team whether a trial fits you.
- Phase 1/2Taking peopleA study to evaluate safety and clinical activity of GSK5926371 in adult participants with relapsed or refractory B-NHL
- Where
- Helsinki, Tampere
- Age
- 18 years and over
- People
- 30 worldwide
- Run by
- Glaxosmithkline Research & Development Limited
See details and how to join2025-524915-36-00 - Phase 3Taking peopleA long-term follow-up study for patients treated with Galapagos CAR T cell therapies
- Where
- Helsinki
- Age
- 18 years and over
- People
- 309 worldwide
- Run by
- Lakefront Biotherapeutics
See details and how to join2023-510173-34-00